ResearcherHudsonAlpha Institute for BiotechnologyNo recent work listed

R Myers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9701-676X; OpenAlex author ID A5016212527. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mes… Co-author DOI 10.1186/s12885-021-08388-1 ↗
RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4. Last author DOI 10.1016/j.molonc.2016.05.004 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ryne C. Ramaker · 2 shared papers, 2016–2021 · strength 0.21
- Paper Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resist… DOI 10.1186/s12885-021-08388-1 ↗
- Paper RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival … DOI 10.1016/j.molonc.2016.05.004 ↗
Sara J. Cooper · 2 shared papers, 2016–2021 · strength 0.21
- Paper Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resist… DOI 10.1186/s12885-021-08388-1 ↗
- Paper RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival … DOI 10.1016/j.molonc.2016.05.004 ↗
Carter Wright · 1 shared paper, 2021 · strength 0.16
- Paper Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resist… DOI 10.1186/s12885-021-08388-1 ↗
Emily R. Gordon · 1 shared paper, 2021 · strength 0.16
- Paper Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resist… DOI 10.1186/s12885-021-08388-1 ↗
Selwyn Maurice Vickers · 1 shared paper, 2016 · strength 0.05
- Paper RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival … DOI 10.1016/j.molonc.2016.05.004 ↗
Donald J Buchsbaum · 1 shared paper, 2016 · strength 0.05
- Paper RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival … DOI 10.1016/j.molonc.2016.05.004 ↗
John D. Christein · 1 shared paper, 2016 · strength 0.05
- Paper RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival … DOI 10.1016/j.molonc.2016.05.004 ↗
Martin J. Heslin · 1 shared paper, 2016 · strength 0.05
- Paper RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival … DOI 10.1016/j.molonc.2016.05.004 ↗
Marie K. Kirby · 1 shared paper, 2016 · strength 0.05
- Paper RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival … DOI 10.1016/j.molonc.2016.05.004 ↗
James A. Posey · 1 shared paper, 2016 · strength 0.05
- Paper RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival … DOI 10.1016/j.molonc.2016.05.004 ↗
Edward W. Greeno · 1 shared paper, 2016 · strength 0.05
- Paper RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival … DOI 10.1016/j.molonc.2016.05.004 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.